Who we are
Quantgene combines biotechnology, AI and cloud to build the future of medicine. Our mission is to extend our members’ lifespan by a decade within a decade through cutting edge genomics, data science and medical process innovation.
Quantgene has been recognized by the California Senate as a world leader in genomics innovation. Quantgene combines biotechnology, AI and cloud systems to build the future of genomic medicine. Our mission is to extend our members’ lifespan by a decade within a decade.
Over the last 6 years, Quantgene has developed the world’s 1st medical solution (SERENITY) for genomics-based early cancer detection in blood samples (liquid biopsy). Detecting cancers at early stages can improve 5-year survival rates by 10 times or more. SERENITY is now being launched in key US metropolitan regions.
Quantgene’s genomics technology has been developed in clinical trials with institutions including City of Hope National Medical Center (#1 cancer hospital in the West), Cedar Sinai and Kettering Cancer Centers. Health Networks clinical trials include AdventHealth (#1 largest US hospital, #5 largest US hospital network), Prisma Health, Orlando Health and others.
Quantgene’s original research has been published in the [#1 leading] oncology journals Cancers and Genes. Our technology partners include Thermo Fisher (NYSE: TMO), PerkinElmer (NYSE: PKI) and Fulgent (NASDAQ: FLGT).
The Director of Business Development will identify external growth opportunities, drive partnering processes, negotiate agreements, and creatively address complex business challenges by cultivating external relationships and collaborations.
Salary and Benefits
Location - Santa Monica
Valid through: 12/17/2021